The Global Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 180 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
Industry Overview
1.1 Definition and Specifications of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
1.2 Classification of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
1.3 Applications of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
1.4 Industry Chain Structure of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
1.5 Industry Regional Overview of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
1.6 Industry Policy Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
1.7 Industry News Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
2 Manufacturing Cost Structure Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
2.1 Raw Material Suppliers and Price Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
2.2 Equipment Suppliers and Price Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
2.3 Labor Cost Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
2.4 Other Costs Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
2.5 Manufacturing Cost Structure Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
2.6 Manufacturing Process Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Manufacturers in 2014
3.3 R&D Status and Technology Source of Global Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Key Manufacturers in 2014
4 Production Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) by Regions, Technology, and Applications
4.1 Global Production of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) by Regions (US, EU, China, Japan, etc.) 2010-2015
4.2 Global Production of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) by Technology 2010-2015
4.3 Global Production of '& B1 &' by Applications 2010-2015
4.4 Price Analysis of Global Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost and Revenue of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
4.6 EU Capacity, Production, Price, Cost and Revenue of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
4.7 Japan Capacity, Production, Price, Cost and Revenue of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
4.8 China Capacity, Production, Price, Cost and Revenue of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
4.9 US Supply, Import, Export and Consumption of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
4.10 EU Supply, Import, Export and Consumption of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
4.11 Japan Supply, Import, Export and Consumption of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
4.12 China Supply, Import, Export and Consumption of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
5 Sales and Revenue Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) by Regions
5.1 Global Sales of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) by Regions (US, EU, China, Japan, etc.) 2010-2015
5.2 Global Revenue of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) by Regions (US, EU, China, Japan, etc.) 2010-2015
5.3 Global Price Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Sales by Regions (US, EU, China, Japan, etc.) 2010-2015
5.4 Global Price, Cost and Gross of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
6 Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
6.2 Production Market Share Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
6.3 Sales Overview of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
6.4 Supply, Sales and Shortage of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
6.5 Import, Export and Consumption of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2010-2015
7 Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Industry Key Manufacturers
7.1 Pfizer, Inc.
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity Production Price Cost Production Value
7.1.4 Contact Information
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity Production Price Cost Production Value
7.2.4 Contact Information
7.3 GlaxoSmithKline plc
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity Production Price Cost Production Value
7.3.4 Contact Information
7.4 Genoptix, Inc.
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity Production Price Cost Production Value
7.4.4 Contact Information
7.5 Eli Lilly and Company
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity Production Price Cost Production Value
7.5.4 Contact Information
7.6 bioMeriux SA
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity Production Price Cost Production Value
7.6.4 Contact Information
7.7 AstraZeneca plc
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity Production Price Cost Production Value
7.7.4 Contact Information
7.8 Ambry Genetics
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity Production Price Cost Production Value
7.8.4 Contact Information
7.9 Abbott Laboratories, Inc.
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity Production Price Cost Production Value
7.9.4 Contact Information
8 Price and Gross Margin Analysis
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Product Types
8.5 Market Share Analysis of Different Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Price Levels
8.6 Gross Margin Analysis of Different Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Applications
9 Marketing Trader or Distributor Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
9.1 Marketing Channels Status of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
9.2 Traders or Distributors of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
9.4 Regional Import, Export and Trade Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
10 Development Trend of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Industry 2015-2020
10.1 Capacity and Production Overview of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2015-2020
10.2 Production Market Share Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2015-2020
10.3 Sales Overview of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2015-2020
10.4 Supply, Sales, and Shortage of '& B1 &' 2015-2020
10.5 Import, Export and Consumption of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) 2015-2020
11 Industry Chain Suppliers of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) with Contact Information
11.1 Major Raw Materials Suppliers of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) with Contact Information
11.2 Manufacturing Equipment Suppliers of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) with Contact Information
11.3 Major Suppliers of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) with Contact Information
11.4 Key Consumers of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) with Contact Information
11.5 Supply Chain Relationship Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
12 New Project Investment Feasibility Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
12.1 New Project SWOT Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
12.2 New Project Investment Feasibility Analysis of Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy)
13 Conclusion of the Global Cancer Diagnostics (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Industry Report 2015
